Glaucoma Pharmaceuticals market worldwide is projected to grow by US$1. 3 Billion, driven by a compounded growth of 3%. Hospitals, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.

New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Glaucoma Pharmaceuticals Industry" - https://www.reportlinker.com/p05817992/?utm_source=GNW
2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.4 Billion by the year 2025, Hospitals will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 2.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$50.8 Million to the region’s size and clout in the next 5 to 6 years. Over US$40.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hospitals will reach a market size of US$263.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 4.5% over the next couple of years and add approximately US$361.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Aerie Pharmaceuticals, Inc.; Allergan PLC; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Santen Pharmaceuticals Co., Ltd.


Read the full report: https://www.reportlinker.com/p05817992/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Glaucoma Pharmaceuticals Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Glaucoma Pharmaceuticals Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Glaucoma Pharmaceuticals Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Glaucoma Pharmaceuticals Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Hospitals (End-Use) Global Opportunity Assessment in
US$ Million by Region/Country: 2018-2025
Table 5: Hospitals (End-Use) Historic Sales Analysis in US$
Million by Region/Country: 2009-2017
Table 6: Hospitals (End-Use) Percentage Share Breakdown of
Global Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Ophthalmic Clinics (End-Use) Worldwide Sales in US$
Million by Region/Country: 2018-2025
Table 8: Ophthalmic Clinics (End-Use) Historic Demand Patterns
in US$ Million by Region/Country: 2009-2017
Table 9: Ophthalmic Clinics (End-Use) Market Share Shift across
Key Geographies: 2009 VS 2019 VS 2025
Table 10: Ambulatory Surgical Centers (End-Use) Global Market
Estimates & Forecasts in US$ Million by Region/Country:
2018-2025
Table 11: Ambulatory Surgical Centers (End-Use) Retrospective
Demand Analysis in US$ Million by Region/Country: 2009-2017
Table 12: Ambulatory Surgical Centers (End-Use) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 13: Prostaglandins (Drug Class) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Prostaglandins (Drug Class) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Prostaglandins (Drug Class) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Beta Blockers (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Beta Blockers (Drug Class) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 18: Beta Blockers (Drug Class) Market Share Distribution
in Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Alpha Agonists (Drug Class) World Market Estimates
and Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Alpha Agonists (Drug Class) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Alpha Agonists (Drug Class) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Carbonic Anhydrase Inhibitors (Drug Class) Market
Opportunity Analysis Worldwide in US$ Million by
Region/Country: 2018 to 2025
Table 23: Carbonic Anhydrase Inhibitors (Drug Class) Global
Historic Demand in US$ Million by Region/Country: 2009 to 2017
Table 24: Carbonic Anhydrase Inhibitors (Drug Class) Market
Share Distribution in Percentage by Region/Country: 2009 VS
2019 VS 2025
Table 25: Combination Medications (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 26: Combination Medications (Drug Class) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 27: Combination Medications (Drug Class) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 28: Cholinergics (Drug Class) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 29: Cholinergics (Drug Class) Historic Market Perspective
by Region/Country in US$ Million: 2009 to 2017
Table 30: Cholinergics (Drug Class) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Glaucoma Pharmaceuticals Market Share (in %) by Company:
2019 & 2025
Table 31: United States Glaucoma Pharmaceuticals Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 32: Glaucoma Pharmaceuticals Historic Demand Patterns in
the United States by End-Use in US$ Million for 2009-2017
Table 33: Glaucoma Pharmaceuticals Market Share Breakdown in
the United States by End-Use: 2009 VS 2019 VS 2025
Table 34: United States Glaucoma Pharmaceuticals Market
Estimates and Projections in US$ Million by Drug Class: 2018 to
2025
Table 35: Glaucoma Pharmaceuticals Market in the United States
by Drug Class: A Historic Review in US$ Million for 2009-2017
Table 36: United States Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
CANADA
Table 37: Canadian Glaucoma Pharmaceuticals Market Quantitative
Demand Analysis in US$ Million by End-Use: 2018 to 2025
Table 38: Glaucoma Pharmaceuticals Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 39: Canadian Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 40: Canadian Glaucoma Pharmaceuticals Market Estimates
and Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 41: Canadian Glaucoma Pharmaceuticals Historic Market
Review by Drug Class in US$ Million: 2009-2017
Table 42: Glaucoma Pharmaceuticals Market in Canada: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
JAPAN
Table 43: Japanese Demand Estimates and Forecasts for Glaucoma
Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
Table 44: Japanese Glaucoma Pharmaceuticals Market in US$
Million by End-Use: 2009-2017
Table 45: Glaucoma Pharmaceuticals Market Share Shift in Japan
by End-Use: 2009 VS 2019 VS 2025
Table 46: Japanese Market for Glaucoma Pharmaceuticals: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 47: Glaucoma Pharmaceuticals Market in Japan: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2009-2017
Table 48: Japanese Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
CHINA
Table 49: Chinese Demand for Glaucoma Pharmaceuticals in US$
Million by End-Use: 2018 to 2025
Table 50: Glaucoma Pharmaceuticals Market Review in China in
US$ Million by End-Use: 2009-2017
Table 51: Chinese Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 52: Chinese Glaucoma Pharmaceuticals Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 53: Glaucoma Pharmaceuticals Historic Market Analysis in
China in US$ Million by Drug Class: 2009-2017
Table 54: Chinese Glaucoma Pharmaceuticals Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Glaucoma Pharmaceuticals Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 55: European Glaucoma Pharmaceuticals Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 56: Glaucoma Pharmaceuticals Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 57: European Glaucoma Pharmaceuticals Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 58: European Glaucoma Pharmaceuticals Addressable Market
Opportunity in US$ Million by End-Use: 2018-2025
Table 59: Glaucoma Pharmaceuticals Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 60: European Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 61: European Glaucoma Pharmaceuticals Market Estimates
and Forecasts in US$ Million by Drug Class: 2018-2025
Table 62: Glaucoma Pharmaceuticals Market in Europe in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 63: European Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
FRANCE
Table 64: Glaucoma Pharmaceuticals Quantitative Demand Analysis
in France in US$ Million by End-Use: 2018-2025
Table 65: French Glaucoma Pharmaceuticals Historic Market
Review in US$ Million by End-Use: 2009-2017
Table 66: French Glaucoma Pharmaceuticals Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
Table 67: Glaucoma Pharmaceuticals Market in France by Drug
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 68: French Glaucoma Pharmaceuticals Historic Market
Scenario in US$ Million by Drug Class: 2009-2017
Table 69: French Glaucoma Pharmaceuticals Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
GERMANY
Table 70: Glaucoma Pharmaceuticals Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 71: German Glaucoma Pharmaceuticals Market in Retrospect
in US$ Million by End-Use: 2009-2017
Table 72: Glaucoma Pharmaceuticals Market Share Distribution in
Germany by End-Use: 2009 VS 2019 VS 2025
Table 73: Glaucoma Pharmaceuticals Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 74: German Glaucoma Pharmaceuticals Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 75: German Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
ITALY
Table 76: Italian Demand for Glaucoma Pharmaceuticals in US$
Million by End-Use: 2018 to 2025
Table 77: Glaucoma Pharmaceuticals Market Review in Italy in
US$ Million by End-Use: 2009-2017
Table 78: Italian Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 79: Italian Glaucoma Pharmaceuticals Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 80: Glaucoma Pharmaceuticals Historic Market Analysis in
Italy in US$ Million by Drug Class: 2009-2017
Table 81: Italian Glaucoma Pharmaceuticals Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 82: United Kingdom Demand Estimates and Forecasts for
Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to
2025
Table 83: United Kingdom Glaucoma Pharmaceuticals Market in US$
Million by End-Use: 2009-2017
Table 84: Glaucoma Pharmaceuticals Market Share Shift in the
United Kingdom by End-Use: 2009 VS 2019 VS 2025
Table 85: United Kingdom Market for Glaucoma Pharmaceuticals:
Annual Sales Estimates and Projections in US$ Million by Drug
Class for the Period 2018-2025
Table 86: Glaucoma Pharmaceuticals Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Drug Class
for the Period 2009-2017
Table 87: United Kingdom Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
SPAIN
Table 88: Spanish Glaucoma Pharmaceuticals Market Quantitative
Demand Analysis in US$ Million by End-Use: 2018 to 2025
Table 89: Glaucoma Pharmaceuticals Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 90: Spanish Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 91: Spanish Glaucoma Pharmaceuticals Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 92: Spanish Glaucoma Pharmaceuticals Historic Market
Review by Drug Class in US$ Million: 2009-2017
Table 93: Glaucoma Pharmaceuticals Market in Spain: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
RUSSIA
Table 94: Russian Glaucoma Pharmaceuticals Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 95: Glaucoma Pharmaceuticals Historic Demand Patterns in
Russia by End-Use in US$ Million for 2009-2017
Table 96: Glaucoma Pharmaceuticals Market Share Breakdown in
Russia by End-Use: 2009 VS 2019 VS 2025
Table 97: Russian Glaucoma Pharmaceuticals Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 98: Glaucoma Pharmaceuticals Market in Russia by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 99: Russian Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 100: Rest of Europe Glaucoma Pharmaceuticals Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 101: Glaucoma Pharmaceuticals Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 102: Rest of Europe Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 103: Rest of Europe Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Table 104: Glaucoma Pharmaceuticals Market in Rest of Europe in
US$ Million by Drug Class: A Historic Review for the Period
2009-2017
Table 105: Rest of Europe Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 106: Asia-Pacific Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 107: Glaucoma Pharmaceuticals Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 108: Asia-Pacific Glaucoma Pharmaceuticals Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 109: Glaucoma Pharmaceuticals Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
Table 110: Asia-Pacific Glaucoma Pharmaceuticals Historic
Market Review in US$ Million by End-Use: 2009-2017
Table 111: Asia-Pacific Glaucoma Pharmaceuticals Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
Table 112: Glaucoma Pharmaceuticals Market in Asia-Pacific by
Drug Class: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 113: Asia-Pacific Glaucoma Pharmaceuticals Historic
Market Scenario in US$ Million by Drug Class: 2009-2017
Table 114: Asia-Pacific Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
AUSTRALIA
Table 115: Glaucoma Pharmaceuticals Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 116: Australian Glaucoma Pharmaceuticals Market in
Retrospect in US$ Million by End-Use: 2009-2017
Table 117: Glaucoma Pharmaceuticals Market Share Distribution
in Australia by End-Use: 2009 VS 2019 VS 2025
Table 118: Glaucoma Pharmaceuticals Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 119: Australian Glaucoma Pharmaceuticals Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 120: Australian Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
INDIA
Table 121: Indian Glaucoma Pharmaceuticals Market Quantitative
Demand Analysis in US$ Million by End-Use: 2018 to 2025
Table 122: Glaucoma Pharmaceuticals Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 123: Indian Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 124: Indian Glaucoma Pharmaceuticals Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 125: Indian Glaucoma Pharmaceuticals Historic Market
Review by Drug Class in US$ Million: 2009-2017
Table 126: Glaucoma Pharmaceuticals Market in India: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
SOUTH KOREA
Table 127: Glaucoma Pharmaceuticals Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
End-Use for the Period 2018-2025
Table 128: South Korean Glaucoma Pharmaceuticals Historic
Market Analysis in US$ Million by End-Use: 2009-2017
Table 129: Glaucoma Pharmaceuticals Market Share Distribution
in South Korea by End-Use: 2009 VS 2019 VS 2025
Table 130: Glaucoma Pharmaceuticals Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Drug
Class for the Period 2018-2025
Table 131: South Korean Glaucoma Pharmaceuticals Historic
Market Analysis in US$ Million by Drug Class: 2009-2017
Table 132: Glaucoma Pharmaceuticals Market Share Distribution
in South Korea by Drug Class: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 133: Rest of Asia-Pacific Demand Estimates and Forecasts
for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to
2025
Table 134: Rest of Asia-Pacific Glaucoma Pharmaceuticals Market
in US$ Million by End-Use: 2009-2017
Table 135: Glaucoma Pharmaceuticals Market Share Shift in Rest
of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025
Table 136: Rest of Asia-Pacific Market for Glaucoma
Pharmaceuticals: Annual Sales Estimates and Projections in US$
Million by Drug Class for the Period 2018-2025
Table 137: Glaucoma Pharmaceuticals Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Drug
Class for the Period 2009-2017
Table 138: Rest of Asia-Pacific Glaucoma Pharmaceuticals Market
Share Analysis by Drug Class: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 139: Latin American Glaucoma Pharmaceuticals Market
Trends by Region/Country in US$ Million: 2018-2025
Table 140: Glaucoma Pharmaceuticals Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 141: Latin American Glaucoma Pharmaceuticals Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 142: Latin American Demand for Glaucoma Pharmaceuticals
in US$ Million by End-Use: 2018 to 2025
Table 143: Glaucoma Pharmaceuticals Market Review in Latin
America in US$ Million by End-Use: 2009-2017
Table 144: Latin American Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 145: Latin American Glaucoma Pharmaceuticals Market
Growth Prospects in US$ Million by Drug Class for the Period
2018-2025
Table 146: Glaucoma Pharmaceuticals Historic Market Analysis in
Latin America in US$ Million by Drug Class: 2009-2017
Table 147: Latin American Glaucoma Pharmaceuticals Market by
Drug Class: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 148: Argentinean Glaucoma Pharmaceuticals Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 149: Glaucoma Pharmaceuticals Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 150: Argentinean Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 151: Argentinean Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Table 152: Glaucoma Pharmaceuticals Market in Argentina in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 153: Argentinean Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
BRAZIL
Table 154: Glaucoma Pharmaceuticals Quantitative Demand
Analysis in Brazil in US$ Million by End-Use: 2018-2025
Table 155: Brazilian Glaucoma Pharmaceuticals Historic Market
Review in US$ Million by End-Use: 2009-2017
Table 156: Brazilian Glaucoma Pharmaceuticals Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
Table 157: Glaucoma Pharmaceuticals Market in Brazil by Drug
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 158: Brazilian Glaucoma Pharmaceuticals Historic Market
Scenario in US$ Million by Drug Class: 2009-2017
Table 159: Brazilian Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
MEXICO
Table 160: Glaucoma Pharmaceuticals Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 161: Mexican Glaucoma Pharmaceuticals Market in
Retrospect in US$ Million by End-Use: 2009-2017
Table 162: Glaucoma Pharmaceuticals Market Share Distribution
in Mexico by End-Use: 2009 VS 2019 VS 2025
Table 163: Glaucoma Pharmaceuticals Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 164: Mexican Glaucoma Pharmaceuticals Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 165: Mexican Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 166: Rest of Latin America Glaucoma Pharmaceuticals
Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
Table 167: Glaucoma Pharmaceuticals Historic Demand Patterns in
Rest of Latin America by End-Use in US$ Million for 2009-2017
Table 168: Glaucoma Pharmaceuticals Market Share Breakdown in
Rest of Latin America by End-Use: 2009 VS 2019 VS 2025
Table 169: Rest of Latin America Glaucoma Pharmaceuticals
Market Estimates and Projections in US$ Million by Drug Class:
2018 to 2025
Table 170: Glaucoma Pharmaceuticals Market in Rest of Latin
America by Drug Class: A Historic Review in US$ Million for
2009-2017
Table 171: Rest of Latin America Glaucoma Pharmaceuticals
Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 172: The Middle East Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 173: Glaucoma Pharmaceuticals Market in the Middle East
by Region/Country in US$ Million: 2009-2017
Table 174: The Middle East Glaucoma Pharmaceuticals Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 175: The Middle East Glaucoma Pharmaceuticals Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 176: Glaucoma Pharmaceuticals Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 177: The Middle East Glaucoma Pharmaceuticals Market
Share Analysis by End-Use: 2009 VS 2019 VS 2025
Table 178: The Middle East Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Drug Class: 2018 to
2025
Table 179: The Middle East Glaucoma Pharmaceuticals Historic
Market by Drug Class in US$ Million: 2009-2017
Table 180: Glaucoma Pharmaceuticals Market in the Middle East:
Percentage Share Breakdown of Sales by Drug Class for 2009,
2019, and 2025
IRAN
Table 181: Iranian Demand Estimates and Forecasts for Glaucoma
Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
Table 182: Iranian Glaucoma Pharmaceuticals Market in US$
Million by End-Use: 2009-2017
Table 183: Glaucoma Pharmaceuticals Market Share Shift in Iran
by End-Use: 2009 VS 2019 VS 2025
Table 184: Iranian Market for Glaucoma Pharmaceuticals: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 185: Glaucoma Pharmaceuticals Market in Iran: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2009-2017
Table 186: Iranian Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
ISRAEL
Table 187: Israeli Glaucoma Pharmaceuticals Addressable Market
Opportunity in US$ Million by End-Use: 2018-2025
Table 188: Glaucoma Pharmaceuticals Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 189: Israeli Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 190: Israeli Glaucoma Pharmaceuticals Market Estimates
and Forecasts in US$ Million by Drug Class: 2018-2025
Table 191: Glaucoma Pharmaceuticals Market in Israel in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 192: Israeli Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 193: Saudi Arabian Demand for Glaucoma Pharmaceuticals in
US$ Million by End-Use: 2018 to 2025
Table 194: Glaucoma Pharmaceuticals Market Review in Saudi
Arabia in US$ Million by End-Use: 2009-2017
Table 195: Saudi Arabian Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 196: Saudi Arabian Glaucoma Pharmaceuticals Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 197: Glaucoma Pharmaceuticals Historic Market Analysis in
Saudi Arabia in US$ Million by Drug Class: 2009-2017
Table 198: Saudi Arabian Glaucoma Pharmaceuticals Market by
Drug Class: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED ARAB EMIRATES
Table 199: Glaucoma Pharmaceuticals Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2018-2025
Table 200: United Arab Emirates Glaucoma Pharmaceuticals
Historic Market Analysis in US$ Million by End-Use: 2009-2017
Table 201: Glaucoma Pharmaceuticals Market Share Distribution
in United Arab Emirates by End-Use: 2009 VS 2019 VS 2025
Table 202: Glaucoma Pharmaceuticals Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Drug Class for the Period 2018-2025
Table 203: United Arab Emirates Glaucoma Pharmaceuticals
Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 204: Glaucoma Pharmaceuticals Market Share Distribution
in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 205: Glaucoma Pharmaceuticals Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
End-Use for the Period 2018-2025
Table 206: Rest of Middle East Glaucoma Pharmaceuticals Market
in Retrospect in US$ Million by End-Use: 2009-2017
Table 207: Glaucoma Pharmaceuticals Market Share Distribution
in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025
Table 208: Glaucoma Pharmaceuticals Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Drug Class for the Period 2018-2025
Table 209: Rest of Middle East Glaucoma Pharmaceuticals
Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 210: Rest of Middle East Glaucoma Pharmaceuticals Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
AFRICA
Table 211: African Glaucoma Pharmaceuticals Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 212: Glaucoma Pharmaceuticals Historic Demand Patterns in
Africa by End-Use in US$ Million for 2009-2017
Table 213: Glaucoma Pharmaceuticals Market Share Breakdown in
Africa by End-Use: 2009 VS 2019 VS 2025
Table 214: African Glaucoma Pharmaceuticals Market Estimates
and Projections in US$ Million by Drug Class: 2018 to 2025
Table 215: Glaucoma Pharmaceuticals Market in Africa by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 216: African Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

AERIE PHARMACEUTICALS
ALLERGAN PLC
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PFIZER
SANTEN PHARMACEUTICAL

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817992/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001